Reaction Details Report a problem with these data
Target
Dimer of Gag-Pol polyprotein [489-587]
Ligand
BDBM1006
Substrate
Peptide Substrate
Meas. Tech.
Protease Inhibition Assay
pH
5±n/a
Temperature
295.15±n/a K
Ki
23±n/a nM
Citation
 Turner, SR; Strohbach, JW; Tommasi, RA; Aristoff, PA; Johnson, PD; Skulnick, HI; Dolak, LA; Seest, EP; Tomich, PK; Bohanon, MJ; Horng, MM; Lynn, JC; Chong, KT; Hinshaw, RR; Watenpaugh, KD; Janakiraman, MN; Thaisrivongs, S Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J Med Chem 41:3467-76 (1998) [PubMed]  Article 
Target
Name:
Dimer of Gag-Pol polyprotein [489-587]
Synonyms:
HIV-1 Protease
Type:
Protein Complex
Mol. Mass.:
n/a
Description:
n/a
Components:
This complex has 2 components.
Component 1
Name:
Gag-Pol polyprotein [489-587]
Synonyms:
HIV protease | HIV-1 Protease (NY5-type sequence) | HIV-1 Protease chain A | HIV-1 Protease chain B | POL_HV1N5 | gag-pol
Type:
Enzyme Subunit
Mol. Mass.:
10822.21
Organism:
Human immunodeficiency virus type 1
Description:
P12497[489-587]
Residue:
99
Sequence:
PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
  
Component 2
Name:
Gag-Pol polyprotein [489-587]
Synonyms:
HIV protease | HIV-1 Protease (NY5-type sequence) | HIV-1 Protease chain A | HIV-1 Protease chain B | POL_HV1N5 | gag-pol
Type:
Enzyme Subunit
Mol. Mass.:
10822.21
Organism:
Human immunodeficiency virus type 1
Description:
P12497[489-587]
Residue:
99
Sequence:
PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF
  
Inhibitor
Name:
BDBM1006
Synonyms:
N-[3-(1-{4'-hydroxy-3',6'-dihydrospiro[adamantane-2,2'-pyran]-6'-one}propyl)phenyl]-1-methyl-1H-imidazole-4-sulfonamide | N-[3-[1-(5,6-Dihydro-4-hydroxy-6-oxospirop[2H-pyran-2,2 -tricyclo[3.3.1.1]decan]-5-yl)propyl]phenyl]-1-methyl-1H-imidazole-4-sulfonamide | Tipranavir deriv. 17
Type:
Small organic molecule
Emp. Form.:
C27H33N3O5S
Mol. Mass.:
511.633
SMILES:
CCC(C1C(=O)CC2(OC1=O)C1CC3CC(C1)CC2C3)c1cccc(NS(=O)(=O)c2cn(C)cn2)c1 |TLB:16:15:19:7.12.11,16:11:19:14.15.17,THB:7:11:14:19.17.18,7:18:14:12.16.11,8:7:19:14.15.17,(19.13,-3.15,;17.7,-3.84,;17.7,-5.27,;16.34,-5.92,;15.01,-5.15,;15,-3.75,;13.67,-5.92,;13.67,-7.46,;15.01,-8.23,;16.34,-7.46,;17.61,-8.2,;12.3,-6.76,;11.46,-8.24,;11.46,-9.63,;10.09,-10.33,;10.93,-8.86,;10.93,-7.46,;12.3,-9.55,;13.67,-8.86,;12.83,-10.33,;19.04,-5.95,;20.37,-5.18,;21.7,-5.95,;21.7,-7.49,;20.37,-8.26,;20.37,-9.52,;21.52,-10.68,;20.23,-11.41,;22.53,-11.67,;23.11,-10.68,;24.02,-9.43,;25.48,-9.91,;26.78,-9.31,;25.48,-11.45,;24.02,-11.92,;19.04,-7.49,)|
Structure:
Search PDB for entries with ligand similarity:
Substrate
Name:
Peptide Substrate
Synonyms:
n/a
Type:
Peptide
Mol. Mass.:
1447.64
Organism:
n/a
Description:
The peptide was derivatized with biotin and fluorescein isothiocyanate at the amino and carboxy termini.
Residue:
12
Sequence:
RVSQNYPIVQNK